Moneycontrol PRO
HomeNewsBusinessBuy Natco Pharma, Aurobindo Pharma, Ajanta Pharma: Ashwani Gujral

Buy Natco Pharma, Aurobindo Pharma, Ajanta Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Natco Pharma, Aurobindo Pharma and Ajanta Pharma.

November 02, 2017 / 12:02 IST

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "For the momentum, Natco Pharma is showing a fresh breakout. It is a buy with a stop loss of Rs 985 for target of Rs 1,040. Aurobindo Pharma is a buy with a stop loss of Rs 780 for target of Rs 835. Ajanta Pharma is a buy with a stop loss of Rs 790 and target of Rs 820."

"Future Lifestyle is now getting into some kind of consolidation and finding it difficult to move forward after having moved a lot. My sense is that basically Rs 340-380 is type of range. I don’t see fresh a breakout immediately. Possibly all of these stocks needs to move sideways before they move forward," he said.

At 11:58 hrs Ajanta Pharma was quoting at Rs 1,236.70, up Rs 27.80, or 2.30 percent. It has touched an intraday high of Rs 1,267.80 and an intraday low of Rs 1,210.00.

first published: Nov 2, 2017 12:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347